Drug Trial Radar · NCT06126380
Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
Last checked: Nov 19, 2026Latest source record: Dec 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
132
Planned (sponsor's estimate)
Start
Oct 25, 2023
Primary completion
Dec 2029
Study completion Dec 2029
Sponsor
- Lead sponsor
- Eledon PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Nov 13, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the long term safety and efficacy of AT-1501 (tegoprubart) compared with tacrolimus in patients undergoing kidney transplantation.
Conditions
- Kidney Transplant Rejection
Interventions
AT-1501Drug
AT-1501 20 mg/kg administered every 3 weeks IV + MMF 1000 mg PO twice daily (BID) or MPS 720 mg PO BID + Corticosteroids 5 mg of prednisone PO once daily (QD) or equivalent
TacrolimusDrug
Tacrolimus dosed PO BID with the dose titrated to maintain a trough concentration of 6-8 ng/mL+ MMF 1000 mg PO BID or MPS 720 mg PO BID + Corticosteroids 5 mg of prednisone PO QD or equivalent
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and Tolerability - Incidence of Treatment Emergent Adverse EventsTime frame: Assessed from date of enrollment through Month 48
- Safety and Tolerability - Kidney Transplant Medication Side EffectsTime frame: Assessed from date of enrollment through Month 48
Locations
43 sites in 8 countries. Site status is shown where the registry gives one.
University of California Los Angeles
Los Angeles, California
Keck School of Medicine of USC
Los Angeles, California
University of California, Irvine Medical Center
Orange, California
University of California, Davis Medical Center
Sacramento, California
Jacobs Medical Center at UC San Diego Health
San Diego, California
MedStar Georgetown University Hospital
Washington D.C., District of Columbia
Tampa General Hospital
Tampa, Florida
Emory University Hospital
Atlanta, Georgia
Augusta University
Augusta, Georgia
University of Chicago
Chicago, Illinois
Loyola University Medical Center
Maywood, Illinois
University of Kansas Medical Center
Kansas City, Kansas
Tulane Medical Center
New Orleans, Louisiana
John Hopkins University
Baltimore, Maryland
Massachusetts General Hospital
Boston, Massachusetts
Henry Ford Health System
Detroit, Michigan
University of Minnesota Medical Center
Minneapolis, Minnesota
Mayo Clinic
Rochester, Minnesota
Washington University in St. Louis
St Louis, Missouri
University of Nebraska Medical Center
Omaha, Nebraska
New York University Langone Health - Tisch Hospital
New York, New York
Duke University Medical Center
Durham, North Carolina
University of Cincinnati Medical Center
Cincinnati, Ohio
University of Pittsburgh Medical Center
Harrisburg, Pennsylvania
UT Southwestern
Dallas, Texas
Virginia Commonwealth University
Richmond, Virginia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Fiona Stanley Hospital
Perth, Western Australia, Australia
Fundação Oswaldo Ramos - Hospital do Rim
São Paulo, Brazil
Hospital das Clínicas da Faculdade de Medicina de São Paulo
São Paulo, Brazil
St. Paul's Hospital
Vancouver, British Columbia, Canada
McGill University Health Care Centre
Montreal, Quebec, Canada
Groupe Hospitalier Pellegrin
Bordeaux, France
CHU Grenoble-Alpes - Hopital Nord Michallon
Grenoble, France
Centre Hospitalier Universitaire Dupuytren
Limoges, France
CHU de Toulouse - Hopital de Rangueil
Toulouse, France
Charite Universitatsmedizin Berlin
Berlin, Germany
Hospital del Mar - Parc de Salut Mar
Barcelona, Spain
Hospital Universitari Vall d'Hebron
Barcelona, Spain
Hospital Clinical de Barcelona
Barcelona, Spain
Showing 40 of 43 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.